Integrating artificial intelligence and advanced analytics throughout operations offers pharma companies a pathway to offset impending drug patent expirations.
Alan Kalton
Advertisement
Articles by Alan Kalton
Top industry experts weigh in on what the new year holds for the pharma industry.
Exposing the truth behind AI myths highlighted by COVID.
Advertisement
Latest Updated Articles
Fortifying Defenses Pre-Patent CliffPublished: September 8th 2023 | Updated: September 12th 2023
Top 5 Most Perpetuated AI Myths, DebunkedPublished: May 6th 2021 | Updated: May 12th 2021
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
Leading in the Psychedelic Space: Q&A with Tarek Rabah
5